Titan Pharmaceuticals, Inc. (TTNP)
Largest Insider Buys in Sector
TTNP Stock Price History Chart
TTNP Stock Performance
About Titan Pharmaceuticals, Inc.
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the …
Insider Activity of Titan Pharmaceuticals, Inc.
Over the last 12 months, insiders at Titan Pharmaceuticals, Inc. have bought $0 and sold $0 worth of Titan Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Titan Pharmaceuticals, Inc. have bought $397,648 and sold $441,651 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 20,000 shares for transaction amount of $20,066 was made by Lazar David E. (Chief Executive Officer) on 2023‑01‑25.
List of Insider Buy and Sell Transactions, Titan Pharmaceuticals, Inc.
| 2023-06-21 | Sale | Chief Executive Officer | 359,066 3.9347% | $1.23 | $441,651 | -49.33% | ||
| 2023-01-25 | Chief Executive Officer | 20,000 0.1494% | $1.00 | $20,066 | -43.00% | |||
| 2023-01-24 | Chief Executive Officer | 37,500 0.2755% | $0.97 | $36,221 | -40.82% | |||
| 2022-07-06 | 744,294 5.613% | $0.99 | $739,010 | +3.33% | ||||
| 2018-10-19 | director | 200,000 0.3009% | $0.41 | $81,680 | -36.40% | |||
| 2018-09-24 | director | 500,000 2.3618% | $0.23 | $113,800 | +9.85% | |||
| 2018-09-21 | Executive Chairman | 400,000 2.107% | $0.25 | $100,000 | +10.23% | |||
| 2018-09-21 | See Remarks | 300,000 1.5802% | $0.25 | $75,000 | +10.23% | |||
| 2018-09-21 | director | 200,000 1.0535% | $0.25 | $50,000 | +10.23% | |||
| 2018-09-21 | director | 200,000 1.0535% | $0.25 | $50,000 | +10.23% | |||
| 2018-09-21 | director | 80,000 0.4214% | $0.25 | $20,000 | +10.23% | |||
| 2016-07-19 | director | 5,000 0.023% | $4.68 | $23,400 | -13.54% | |||
| 2016-07-18 | President and CEO | 10,000 0.0474% | $4.96 | $49,550 | -15.82% | |||
| 2016-07-18 | director | 8,000 0.0379% | $4.95 | $39,600 | -15.82% | |||
| 2016-05-31 | director | 20,000 0.0975% | $7.03 | $140,600 | -36.70% | |||
| 2016-02-22 | President and CEO | 11,763 0.0596% | $3.56 | $41,817 | +42.86% | |||
| 2016-01-15 | President and CEO | 5,841 0.0255% | $2.72 | $15,888 | +61.29% | |||
| 2016-01-13 | director | 16,363 0.0756% | $3.16 | $51,707 | +46.63% | |||
| 2016-01-11 | Executive Chairman | 5,000 0.027% | $3.25 | $16,250 | +66.67% | |||
| 2016-01-11 | President and CEO | 17,000 0.0898% | $3.18 | $54,060 | +66.67% |
Insider Historical Profitability
| Activist Investing LLC | 3331402 364.3927% | $3.47 | 1 | 0 | +3.33% | |
| Recli Federico Seghi | director | 800845 87.5974% | $3.47 | 2 | 0 | |
| Rubin Marc | Executive Chairman | 556317 60.8506% | $3.47 | 9 | 0 | |
| BUCALO LOUIS R MD | President and CEO | 550000 60.1596% | $3.47 | 5 | 0 | |
| Kapp Joachim Friedrich | director | 546339 59.7592% | $3.47 | 12 | 5 |